Skip to main content
. 2016 Nov 9;7(51):85235–85243. doi: 10.18632/oncotarget.13252

Figure 5. Kaplan-Meier survival curves by different levels of CDK1 and MAD2L1 expression in 349 LUAD patients.

Figure 5

A. Overall survival (OS) by low and high CDK1 expression; B. Relapse-free survival (RFS) by low and high CDK1 expression; C. Overall survival (OS) by low and high MAD2L1 expression; D. Relapse-free survival (RFS) by low and high MAD2L1 expression.